Cargando…

Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina

BACKGROUND: A first-dose of various vaccines provides acceptable protection against infections by SARS-CoV-2 and evolution to the most severe forms of COVID-19. The recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), was proven efficacious but information about effectiveness in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	González, Soledad, Olszevicki, Santiago, Salazar, Martín, Calabria, Ana, Regairaz, Lorena, Marín, Lupe, Campos, Patricia, Varela, Teresa, Martínez, Veronica V. González, Ceriani, Leticia, Garcia, Enio, Kreplak, Nicolás, Pifano, Marina, Estenssoro, Elisa, Marsico, Franco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435263/ https://www.ncbi.nlm.nih.gov/pubmed/34541480 http://dx.doi.org/10.1016/j.eclinm.2021.101126

Ejemplares similares

Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study
por: González, Soledad, et al.
Publicado: (2022)

Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control study
por: González, Soledad, et al.
Publicado: (2023)

Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
por: Jeewandara, Chandima, et al.
Publicado: (2022)

Bell's palsy after Sputnik V COVID‐19 (Gam‐COVID‐Vac) vaccination
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination: Author's response
por: Pereson, Matías J., et al.
Publicado: (2022)

Assessment of the humoral immunity induced by Sputnik V Covid-19 vaccine (GAM-COVID-VAC) in healthcare workers()
por: Cordova, Ezequiel, et al.
Publicado: (2022)

Assessment of the humoral response to the homologous Gam-COVID-Vac (Sputnik V) or heterologous Sputnik V/mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in dialysis patients
por: Laham, Gustavo, et al.
Publicado: (2022)

Heterologous gam-COVID-vac (sputnik V)/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis
por: Pereson, Matías J., et al.
Publicado: (2022)

WCN23-0034 A COMPARISON OF GAM-COVID-VAC (SPUTNIK V) VACCINE IMMUNOGENICITY IN HEMODIALYSIS PATIENTS AND NON-RENAL SUBJECTS
por: PARSHINA, E., et al.
Publicado: (2023)

ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance
por: Montalti, Marco, et al.
Publicado: (2021)

ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance
por: Di Valerio, Zeno, et al.
Publicado: (2022)

Antibody durability at 1 year after Sputnik V vaccination
por: Sanchez, Lautaro, et al.
Publicado: (2022)

Gam-COVID-Vac (Sputnik V) and Pfizer-BioNTech Vaccines Adverse Events following Immunization in Patients Affected by Parkinson’s Disease and Multiple Sclerosis: A Longitudinal Study
por: Soldà, Giorgia, et al.
Publicado: (2022)

The arrival of Sputnik V
por: Balakrishnan, Vijay Shankar
Publicado: (2020)

Evaluación de la respuesta de los anticuerpos IGG específicos contra SARS-CoV-2 en el personal de salud con el esquema completo de la vacuna Sputnik V (Gam-COVID-Vac)
por: Cordova, Ezequiel, et al.
Publicado: (2022)

Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose
por: Rossi, Andres H., et al.
Publicado: (2021)

Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucumán, Argentina
por: Chahla, Rossana Elena, et al.
Publicado: (2021)

Severe Persistent Eczema in a Recipient of the Gam-COVID-Vac vaccine
por: Ameri, Maryam, et al.
Publicado: (2022)

Sputnik V vaccine goes global
por: Lawton, Graham
Publicado: (2021)

Controversy surrounding the Sputnik V vaccine
por: Cazzola, Mario, et al.
Publicado: (2021)

SG-APSIC1049: Immunogenicity of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in seropositive and seronegative adults
por: Stoma, Igor, et al.
Publicado: (2023)

Comparative immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines: results of a pilot clinical study
por: Stoma, Igor, et al.
Publicado: (2023)

Risk factors for COVID-19 mortality: The effect of convalescent plasma administration
por: Salazar, Martín R., et al.
Publicado: (2021)

Retrospective Cohort Study of the Effectiveness of the Sputnik V and EpiVacCorona Vaccines against the SARS-CoV-2 Delta Variant in Moscow (June–July 2021)
por: Matveeva, Olga, et al.
Publicado: (2022)

Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies
por: Tsimafeyeu, Ilya, et al.
Publicado: (2021)

Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination
por: Astakhova, Ekaterina A., et al.
Publicado: (2022)

Dissection of Antibody Responses of Gam-COVID-Vac-Vaccinated Subjects Suggests Involvement of Epitopes Outside RBD in SARS-CoV-2 Neutralization
por: Byazrova, Maria, et al.
Publicado: (2023)

Mild Facial Paresis in a Recipient of Gam-COVID-Vac Vaccine: A Case Report
por: Mahmoudi Hamidabad, Negin, et al.
Publicado: (2022)

Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students—which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?
por: Houshmand, Behzad, et al.
Publicado: (2022)

Preliminary Results on the Search for l^+ l^- gam gam , \nu\bar\nu gam gam and q\barq gam gam Events in 1993
por: DELPHI Collaboration
Publicado: (2018)

Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort
por: Blanco, Sebastián, et al.
Publicado: (2022)

Longitudinal Follow-Up of the Immunity to SARS-CoV-2 in Health Care Workers in Argentina: Persistence of Humoral Response and Neutralizing Capacity after Sputnik V Vaccination
por: Castro, Eliana F., et al.
Publicado: (2023)

The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac
por: Tonnara, Giuseppe, et al.
Publicado: (2022)

The Features of COVID-19’s Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria
por: Ptushkin, Vadim, et al.
Publicado: (2023)

Long Term Immune Response Produced by the SputnikV Vaccine
por: Martynova, Ekaterina, et al.
Publicado: (2021)

Can children of the Sputnik V vaccine recipients become symptomatic?
por: Mehraeen, Esmaeil, et al.
Publicado: (2021)

Sputnik‐V vaccine‐induced panniculitis as a local reactions
por: Sahraei, Zahra, et al.
Publicado: (2022)

Phenotypic Changes in T and NK Cells Induced by Sputnik V Vaccination
por: Boyko, Anna A., et al.
Publicado: (2023)

Development of Peptic Ulcer following Second Shot of Sputnik V Vaccine: A Case Report and Literature Review of Rare Side Effects of Sputnik V Vaccine
por: Hasanzarrini, Maryam, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jja9ataee2evip2kejlv87h221